How to Switch GLP-1 Telehealth Providers Without Missing a Dose

Last reviewed: September 21, 2026 Last updated: September 21, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Switching GLP-1 telehealth providers without missing a dose requires three coordinated actions: starting the new provider's intake before your current supply runs out, requesting a prescription transfer or upload of your existing records, and scheduling the new shipment to arrive before your last dose. The typical intake-to-shipment window is 7–14 days, so begin the switch at least two weeks before you need the next injection. Providers handle transfers differently—some accept prescription forwarding from your current pharmacy, others require you to upload visit notes or start a new clinical assessment. No federal registry automates GLP-1 prescription migration; you carry the coordination burden.

Why switches happen: pricing, service, and supply

Three factors drive most GLP-1 provider switches: recurring cost, service quality, and medication availability. First-month introductory rates can mislead. MEDVi advertises $179 for the first month of compounded semaglutide injection, but the refill rate rises to $299 per month (MEDVi checkout, captured September 4, 2026). OrderlyMeds structures its entry as a two-month starter pack—$149 total for semaglutide, or $74.50 per month equivalent—then bills $149 monthly ongoing (OrderlyMeds product page, captured September 4, 2026). PlexusDx month-to-month compounded semaglutide injection is $189 every month at every dose, with no introductory discount and no refill jump (PlexusDx product pages, captured July 17–23, 2026).

Service complaints appear across Trustpilot records for several high-volume providers. One captured Eden review describes an 11-day order delay and repeated requests for medical records the customer reports Eden had previously generated (Trustpilot, captured September 4, 2026). OrderlyMeds reviews cite fast charging but slow refunds, non-response to support tickets, delayed shipment, unannounced pharmacy changes, and unwanted marketing contact after opt-out (Trustpilot, captured September 4, 2026). These are individual reports, not aggregate statistics, but they illustrate friction points that prompt transfers.

Compounding pharmacy shortages or individual provider supply chain interruptions occasionally force switches. When a 503A pharmacy pauses production or a provider changes its fulfillment partner, patients receive notice to find alternative supply. Those transitions rarely allow the full two-week buffer.

Normalized month-to-month cost: compounded semaglutide injection

Month-to-month plans let you switch without forfeiting prepaid months. The table below compares verified monthly recurring rates for compounded semaglutide injection, same-dose pricing where confirmed, after any introductory period.

OrderlyMeds holds the lowest advertised ongoing rate at $149 per month, but Trustpilot reviews describe operational friction. PlexusDx is $189 per month with a 4.3-star Trustpilot rating, 79 percent five-star reviews, and 83 percent at four stars or higher (Trustpilot, captured September 9, 2026).

Step-by-step: the mechanical sequence

1. Inventory your current supply and refill schedule

Count remaining doses and note your next scheduled injection date. Check your current provider's account portal for the next auto-refill or subscription charge date. If you have two weeks of supply remaining, you operate within the comfortable window. One week or less introduces timing risk.

2. Start the new provider intake immediately

Most telehealth GLP-1 programs begin with a brief online intake—medical history, current medications, weight goals. Some platforms offer asynchronous provider review within 24–48 hours; others schedule a live video visit that may push the timeline to 5–7 days. Ask the new provider during intake whether they accept prescription transfers from another compounding pharmacy or require new clinical documentation.

3. Request medical records from your current provider

Federal HIPAA rules grant you the right to your medical records, typically within 30 days, though many telehealth platforms produce them faster. Request visit summaries, prescriptions, and dosing history in writing (email or portal message) the same day you start the new intake. Some providers charge a records fee; most telehealth platforms waive it. Upload or forward the records to your new provider's clinical team to expedite dose confirmation and avoid restarting titration.

4. Cancel or pause your current subscription before the next charge

Subscription cancellation policies vary. Month-to-month plans usually allow immediate cancellation, but some providers process the stop only at the end of the current billing cycle. If your next charge posts before the new provider ships, you may pay for overlapping supply. Read the cancellation terms in your account settings or contact support to confirm the effective date. Ask whether a charged-but-unshipped order qualifies for refund if you cancel mid-cycle.

5. Complete the new provider visit and await approval

After intake submission, a licensed clinician reviews your profile. Asynchronous platforms typically approve within 24–72 hours. Synchronous visit platforms schedule the call, then issue the prescription. If you uploaded records showing stable dosing, many clinicians continue your current dose; without records, some restart you at the protocol's initial titration step. Clarify dose continuation during the visit or in your intake notes.

6. Confirm shipment timing and tracking

Once approved, the prescription moves to the compounding pharmacy. Standard fulfillment is 3–7 business days; add 2–5 days for carrier transit. Ask the new provider's support team for the expected ship date and tracking method. If the arrival window overlaps your last dose by fewer than two days, contact the pharmacy to request expedited processing.

7. Verify dose and administration upon arrival

When the package arrives, confirm the vial label matches your prescribed dose and that syringes, alcohol pads, and disposal container are included. If the new provider prescribed a different concentration or volume per dose, follow the updated injection instructions exactly. Do not assume the new vial uses the same unit markings as your prior supply.

What providers require for prescription transfer

Compounded GLP-1 prescriptions are not listed in a centralized federal database like controlled substances. Each telehealth platform uses its own compounding pharmacy network, and those pharmacies do not automatically share records. Transfers depend on the policies of both your outgoing and incoming provider.

Prescription forwarding: Some 503A pharmacies will forward an active prescription to another licensed pharmacy at the patient's written request. This process mirrors the retail-pharmacy transfer workflow. You provide the new pharmacy's name, address, and phone number; your current pharmacy faxes or electronically transmits the prescription details. Not all telehealth platforms support inbound forwarding—some require their own clinician to write a new prescription.

Medical record upload: The more common path is uploading visit notes, lab results, and prescription history during the new provider's intake. The new clinician reviews those records to confirm prior dosing and approves continuation or adjustment. This route avoids inter-pharmacy coordination but requires you to obtain and submit the documents.

New clinical assessment: If you cannot retrieve records or the new provider's protocol mandates an independent evaluation, expect a full intake: weight, BMI, contraindication screening, and sometimes baseline labs. The clinician may restart titration from the lowest protocol dose rather than continuing your current level, adding weeks to reaching therapeutic effect.

Timing gaps and how to manage them

Even with diligent coordination, three failure points create dose gaps:

1. Delayed record release: Your current provider's administrative team may take 7–14 days to produce visit summaries. If the new provider requires those documents before prescribing, the clock starts only after receipt. Solution: request records the moment you decide to switch, before starting the new intake.
2. Asynchronous visit backlog: High patient volume can extend asynchronous review beyond the advertised 24–48 hours. Solution: choose a new provider with live-visit availability or ask the intake coordinator for current review wait times.
3. Pharmacy fulfillment variation: Compounding pharmacies occasionally experience API (active pharmaceutical ingredient) shortages or staff constraints that delay fills by several days. Solution: confirm the pharmacy's current fulfillment window during intake, not after approval.

If a gap becomes unavoidable, discuss with your new provider's clinical team whether skipping one dose requires titration restart or whether you resume at your prior level. Clinical guidance varies by compound, dose, and time elapsed.

Where PlexusDx fits in transfer planning

PlexusDx operates on a transparent month-to-month model with same-dose pricing: compounded semaglutide injection is $189 monthly, compounded tirzepatide injection is $289 monthly, no membership fee, no dose-tier upcharges (PlexusDx product pages, captured July 17–23, 2026). Every plan includes medication, clinical access, and shipping. The 60-second intake feeds an asynchronous clinician review, typically completed within 24–48 hours. Patients upload prior visit notes and prescription records during intake; the reviewing clinician uses those documents to confirm dose continuation, avoiding titration restart when clinically appropriate. The platform works exclusively with licensed 503A compounding pharmacies and does not require multi-month prepayment, so a patient switching in can cancel or adjust without forfeiting sunk cost.

PlexusDx holds a 4.3-star rating on Trustpilot, with 79 percent of reviews at five stars and 83 percent at four stars or higher (Trustpilot, captured September 9, 2026). The clinical model does not guarantee uninterrupted transfers—supply chain, eligibility, and timing variables remain—but the intake-to-shipment median aligns with the 7–10 day window that supports gap-free switches when started two weeks ahead.

Choose PlexusDx if…

• You want month-to-month flexibility without prepay commitment, so switching out later carries no financial penalty.
• Same-dose pricing matters—your next titration step will not trigger a rate increase.
• You prefer to upload prior records during intake and have a clinician confirm dose continuation asynchronously, avoiding appointment scheduling.
• You value a single all-inclusive price with no separate membership or visit fees.

Choose OrderlyMeds if…

• You prioritize the lowest advertised monthly rate ($149 semaglutide, $299 tirzepatide ongoing) and can tolerate the operational friction described in some Trustpilot reviews.
• The two-month starter structure fits your transfer timeline.

Choose Henry Meds if…

• You want an established brand with a 4.4-star Trustpilot rating across ~13,000 reviews and accept the $297 month-to-month semaglutide rate or prefer their oral tirzepatide tablet format.
• You plan to commit to a 6- or 12-month prepaid plan for a lower effective rate and will not need to switch again mid-term.

Choose MEDVi if…

• You are comfortable with the $179 first-month introductory price rising to $299 per month for semaglutide refills, and the 4.3-star Trustpilot rating meets your service-quality threshold.

Choose Found if…

• You want a comprehensive coaching and behavioral program bundled with medication, accept the $289 month-to-month semaglutide rate (cash-pay path), or will prepay $2,028 upfront for 12 months at $169 per month effective.

Choose Eden if…

• The $99 monthly membership plus $99 semaglutide medication ($198 all-in ongoing) aligns with your budget, you value the 4.5-star Trustpilot rating, and you can verify current fulfillment timelines given the delay report captured in reviews.

Methodology and freshness

Pricing, policies, and service ratings were captured from provider websites, checkout verification sessions, and Trustpilot between July 17 and September 9, 2026. MEDVi, OrderlyMeds, and several other providers were verified at checkout on September 4, 2026. PlexusDx pricing was captured July 17–23, 2026, and the Trustpilot rating September 9, 2026. Trustpilot review themes are paraphrased from individual captured reports and do not represent aggregate statistical conclusions. The 7–14 day intake-to-shipment window is a synthesis of advertised timelines across multiple platforms; individual experience may vary by patient volume, pharmacy capacity, and clinical complexity. The 12-month cost calculations for ongoing month-to-month rates are our calculation. Readers should confirm current pricing, transfer policies, and fulfillment windows at checkout and with the provider's support team before initiating a switch.

Frequently Asked Questions

Can I transfer my GLP-1 prescription between telehealth providers the same way I transfer retail pharmacy prescriptions?

Compounded GLP-1 prescriptions are not listed in a centralized database, so automatic transfers do not occur. Some 503A compounding pharmacies will forward a prescription to another licensed pharmacy at your written request, but many telehealth platforms require their own clinician to write a new prescription after reviewing your intake and records. The safest path is uploading prior visit notes and prescription history to the new provider during intake so their clinician can confirm dose continuation.

How long does it take to switch providers without missing a dose?

The typical intake-to-shipment window is 7–14 days, including clinician review, prescription approval, pharmacy compounding, and carrier transit. Starting the new provider intake at least two weeks before your next dose is due provides a comfortable buffer. If your current supply runs out in fewer than 10 days, contact the new provider's support team to ask whether expedited review or fulfillment is available.

Will the new provider continue my current dose or restart titration?

Clinical decisions vary by provider protocol and the documentation you supply. If you upload visit notes and prescription records showing stable dosing and tolerability, many clinicians continue your current dose. Without those records, some providers restart titration from the lowest protocol step to ensure safety and monitor side effects. Clarify the dose-continuation policy during intake or the initial visit.

What happens if my new provider's shipment is delayed and I miss a dose?

Missing one weekly injection may not require restarting titration, but the decision depends on the compound, your dose level, and time elapsed. Contact the new provider's clinical team immediately if a delay creates a gap. They will advise whether to resume at your prior dose or step back. Do not self-administer a double dose or borrow medication from another patient to fill the gap.

Do I need to cancel my current provider before starting the new intake?

No. Start the new intake first, complete the visit, confirm shipment timing, and then cancel the current subscription before its next charge date. Canceling prematurely creates supply risk if the new provider's approval or fulfillment takes longer than expected. Once you have tracking confirmation from the new pharmacy, cancel the old subscription to avoid paying for overlapping supply.

Sources

• PlexusDx product pages (semaglutide injection, tirzepatide injection, semaglutide oral, tirzepatide oral, microdose GLP-1), accessed July 17–23, 2026
• PlexusDx Trustpilot profile (trustpilot.com/review/plexusdx.com), accessed September 9, 2026
• MEDVi website and checkout verification, accessed September 4, 2026
• Henry Meds website and checkout verification, accessed July 17–23, 2026 and September 4, 2026
• Found website and pricing pages, accessed July 17–23, 2026 and September 4, 2026
• Eden website and pricing pages, accessed July 17–23, 2026 and September 4, 2026
• OrderlyMeds website and checkout verification, accessed September 4, 2026
• Fridays Health website, accessed July 17–23, 2026 and September 4, 2026
• Embody, Peak Wellness, TrimRx websites, accessed July 17–23, 2026
• Trustpilot reviews for MEDVi, Henry Meds, Found, Eden, OrderlyMeds, Fridays Health, accessed September 4, 2026
• Federal HIPAA medical records access regulations (HHS.gov), general reference

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. PlexusDx works with licensed 503A compounding pharmacies. A licensed clinician determines whether a prescription is appropriate for an individual patient.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.